The Community Guide

- gsearch

Search Results

Narrow Results:

2022 2
2021 2

Arizona 1
U.S. 1

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

CITE Title : Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 Personal Author(s) : Fowlkes, Ashley L.;Yoon, Sarang K.;Lutrick, Karen;Gwynn, Lisa;Burns, Joy;Grant, Lauren;Phillips, Andrew L.;Ellingson, Katherine;Ferraris, Maria V.;LeClair, Lindsay B.;Mathenge, Clare;Yoo, Young M.;Thiese, Matthew S.;Gerald, Lynn B.;Solle, Natasha Schaefer;Jeddy, Zuha;Odame-Bamfo, Leah;Mak, Josephine;Hegmann, Kurt T.;Gerald, Joe K.;Ochoa, Jezahel S.;Berry, Mark;Rose, Spencer;Lamberte, Julie Mayo;Madhivanan, Purnima;Pubillones, Felipe A.;Rai, Ramona P.;Dunnigan, Kayan;Jones, John T.;Krupp, Karl;Edwards, Laura J.;Bedrick, Edward J.;Sokol, Brian E.;Lowe, Ashley;McLeland-Wieser, Hilary;Jovel, Krystal S.;Fleary, Deanna E.;Khan, Sana M.;Poe, Brandon;Hollister, James;Lopez, Joanna;Rivers, Patrick;Beitel, Shawn;Tyner, Harmony L.;Naleway, Allison L.;Olsho, Lauren E.W.;Caban-Martinez, Alberto J.;Burgess, Jefferey L.;Thompson, Mark G.;Gaglani, Manjusha; Published Date : 3 18 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 71(11):422-428 DOI : http://dx.doi.org/10.15585/MMWRmm7111e1 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Fowlkes, Ashley L. et al. (2022). Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022. 71(11). http://dx.doi.org/10.15585/MMWRmm7111e1 Fowlkes, Ashley L. et al. "Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" 71, no. 11 (2022), http://dx.doi.org/10.15585/MMWRmm7111e1 Fowlkes, Ashley L. et al. "Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" vol. 71, no. 11, 2022, http://dx.doi.org/10.15585/MMWRmm7111e1 Export RIS Citation Information.

:

Fowlkes, Ashley L. ;

Yoon, Sarang K.

3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDC's Advisory Committee on Immunization Practices for persons aged 12-15 year...
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

CITE Title : Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021 Personal Author(s) : Lutrick, Karen;Rivers, Patrick;Yoo, Young M.;Grant, Lauren;Hollister, James;Jovel, Krystal;Khan, Sana;Lowe, Ashley;Baccam, Zoe;Hanson, Hanna;Olsho, Lauren E.W.;Fowlkes, Ashley;Caban-Martinez, Alberto J.;Porter, Cynthia;Yoon, Sarang;Meece, Jennifer;Gaglani, Manjusha;Burns, Joy;Mayo Lamberte, Julie;Nakayima Miiro, Flavia;Bissonnette, Adam;LeClair, Lindsay;Kutty, Preeta K.;Romine, James K.;Stefanski, Elisha;Edwards, Laura J.;Ellingson, Katherine;Gerald, Joe K.;Bedrick, Edward J.;Madhivanan, Purnima;Krupp, Karl;Gerald, Lynn B.;Thompson, Mark;Burgess, Jefferey L.; Published Date : 12 31 2021 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 70(5152):1761-1765 DOI : http://dx.doi.org/10.15585/MMWRmm705152a2 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Lutrick, Karen et al. (2021). Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021. 70(51). http://dx.doi.org/10.15585/MMWRmm705152a2 Lutrick, Karen et al. "Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021" 70, no. 51 (2021), http://dx.doi.org/10.15585/MMWRmm705152a2 Lutrick, Karen et al. "Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021" vol. 70, no. 51, 2021, http://dx.doi.org/10.15585/MMWRmm705152a2 Export RIS Citation Information.

:

Lutrick, Karen ;

Rivers, Patrick

12 31 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine has demonstrated high efficacy in preventing infection with SARS-CoV-2 (the Virus that causes COV...
Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

CITE Title : Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 Personal Author(s) : Fowlkes, Ashley L.;Yoon, Sarang K.;Lutrick, Karen;Gwynn, Lisa;Burns, Joy;Grant, Lauren;Phillips, Andrew L.;Ellingson, Katherine;Ferraris, Maria V.;LeClair, Lindsay B.;Mathenge, Clare;Yoo, Young M.;Thiese, Matthew S.;Gerald, Lynn B.;Solle, Natasha Schaefer;Jeddy, Zuha;Odame-Bamfo, Leah;Mak, Josephine;Hegmann, Kurt T.;Gerald, Joe K.;Ochoa, Jezahel S.;Berry, Mark;Rose, Spencer;Lamberte, Julie Mayo;Madhivanan, Purnima;Pubillones, Felipe A.;Rai, Ramona P.;Dunnigan, Kayan;Jones, John T.;Krupp, Karl;Edwards, Laura J.;Bedrick, Edward J.;Sokol, Brian E.;Lowe, Ashley;McLeland-Wieser, Hilary;Jovel, Krystal S.;Fleary, Deanna E.;Khan, Sana M.;Poe, Brandon;Hollister, James;Lopez, Joanna;Rivers, Patrick;Beitel, Shawn;Tyner, Harmony L.;Naleway, Allison L.;Olsho, Lauren E. W.;Caban-Martinez, Alberto J.;Burgess, Jefferey L.;Thompson, Mark G.;Gaglani, Manjusha; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Rocky Mountain Center for Occupational and Environmental Health;University of Arizona. College of Medicine.;Leonard M. Miller School of Medicine..;Abt Associates, Rockville, Maryland;University of Arizona. College of Public Health.;Baylor Scott & White Health.;St. Luke’s (Duluth, Minnesota);Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region) Texas A&M University. College of Medicine.; Published Date : March 11, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/115393 Fowlkes, Ashley L. et al. (2022). Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022. 71 Fowlkes, Ashley L. et al. "Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" 71 (2022) Fowlkes, Ashley L. et al. "Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" vol. 71, 2022 Export RIS Citation Information.

:

Fowlkes, Ashley L. ;

Yoon, Sarang K.

March 11, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Receipt of 2 doses of Pfizer-BioNTech COVID-19 Vaccine has been shown to be effective in preventing infection ...
A Community Health Worker–Led Community–Clinical Linkage Model to Address Emotional Well-Being Outcomes Among Latino/a People on the US–Mexico Border

CITE Title : A Community Health Worker–Led Community–Clinical Linkage Model to Address Emotional Well-Being Outcomes Among Latino/a People on the US–Mexico Border Personal Author(s) : Lohr, Abby M.;Doubleday, Kevin;Ingram, Maia;Wilkinson-Lee, Ada M.;Coulter, Kiera;Krupp, Karl;Espinoza, Cynthia;Redondo-Martinez, Floribella;David, Cassalyn;Carvajal, Scott C.; Published Date : 8 05 2021 Source : Prev Chronic Dis. 2021; 18 DOI : http://dx.doi.org/10.5888/pcd18.210080 Journal Title : Preventing Chronic Disease (PCD) Lohr, Abby M. et al. (2021). A Community Health Worker–Led Community–Clinical Linkage Model to Address Emotional Well-Being Outcomes Among Latino/a People on the US–Mexico Border. 18http://dx.doi.org/10.5888/pcd18.210080 Lohr, Abby M. et al. "A Community Health Worker–Led Community–Clinical Linkage Model to Address Emotional Well-Being Outcomes Among Latino/a People on the US–Mexico Border" 18 (2021), http://dx.doi.org/10.5888/pcd18.210080 Lohr, Abby M. et al. "A Community Health Worker–Led Community–Clinical Linkage Model to Address Emotional Well-Being Outcomes Among Latino/a People on the US–Mexico Border" vol. 18, 2021, http://dx.doi.org/10.5888/pcd18.210080 Export RIS Citation Information.

:

Lohr, Abby M. ;

Doubleday, Kevin

8 05 2021 | Prev Chronic Dis. 2021; 18

:

IntroductionCompared with their non-Hispanic White counterparts, Latino/a people have limited access to health resources that might improve their emot...